1. Home
  2. WLDN vs OGN Comparison

WLDN vs OGN Comparison

Compare WLDN & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willdan Group Inc.

WLDN

Willdan Group Inc.

HOLD

Current Price

$106.17

Market Cap

1.6B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$7.22

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDN
OGN
Founded
1964
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
WLDN
OGN
Price
$106.17
$7.22
Analyst Decision
Strong Buy
Hold
Analyst Count
3
5
Target Price
$114.33
$14.10
AVG Volume (30 Days)
181.3K
4.6M
Earning Date
11-06-2025
02-12-2026
Dividend Yield
N/A
1.12%
EPS Growth
71.17
N/A
EPS
2.79
1.91
Revenue
$651,926,000.00
$6,301,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.01
N/A
P/E Ratio
$38.81
$3.73
Revenue Growth
12.90
N/A
52 Week Low
$30.43
$6.18
52 Week High
$121.00
$17.23

Technical Indicators

Market Signals
Indicator
WLDN
OGN
Relative Strength Index (RSI) 51.96 49.46
Support Level $107.43 $7.01
Resistance Level $115.00 $7.21
Average True Range (ATR) 4.51 0.21
MACD -0.23 0.05
Stochastic Oscillator 34.76 62.84

Price Performance

Historical Comparison
WLDN
OGN

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: